Powered by Data

Why animal health transactions start with knowing the customer is authorized to receive the product.

In Episode 6, Scott McLean, Brendan Ungemach and John Shoemaker share an inside look at the animal health market, where the data and workflows differ from human health and scrutiny on each transaction keeps growing.

The conversation starts with the practitioner and facility data behind animal health compliance. The panel walks through veterinarian and veterinary technician licenses, controlled substance credentials and why the NPI, a common identifier in human health, rarely applies to veterinarians. They then explain premise licensing, which varies from state to state, with examples such as the Florida healthcare clinic establishment permit, the Ohio terminal distributor of dangerous drugs license and the state rules for mobile clinics.

The panel shares what customers raise most often. Commercial and sales operations teams want to size their market in a field where veterinarians change practice locations often. Compliance and trade teams face growing pressure to confirm a practitioner is active and eligible before an order ships, which is driving more frequent license monitoring and faster delivery of license data into order management systems.

The panel compares the direct-to-vet model, where manufacturers can validate customers at registration and checkout, with the wholesale model, where manufacturers may have limited visibility into the end customer and depend on their distributors to validate each ship-to location.

They close on pharmacy fulfillment. Regulators increasingly ask pharmacies how they validated a prescriber, and the panel explains why independent prescriber license validation gives a pharmacy a stronger answer than the information submitted with a prescription.

Connecting data, engagement, operations and compliance across Life Sciences.

In Episode 5, Scott McLean, Dan Loeffler and Christine Demetillo unpack what it actually takes to build a modern tech stack in Life Sciences and why the data flowing between systems matters more than the platforms themselves.

The conversation walks through the four core layers of the stack (data foundation, engagement, operational and compliance) and how each layer connects to the others. The panel explores why CRM works best as a system of engagement and what happens when organizations try to make it the source of truth.

Through real-world examples, they discuss why capturing data broadly while mastering only what matters outperforms the search for a single source of truth, along with the operational realities of license currency, distribution data and what "real time" actually delivers.

The panel also shares guidance for emerging biotechs building their commercial and compliance foundations and why empowering field teams with compliant freedom drives both growth and operational maturity.

Throughout the discussion, the panel outlines how leading organizations connect their systems, expand their data scope and measure ROI across integrations, MDM implementations and compliance outcomes.

Our panel explores where data quality issues start, why transparency reporting can't be owned by compliance alone and how to strengthen reporting accuracy.

In Episode 4, Scott McLean, Cristina List, Tenille Goodman and Kevin O'Rourke explore one of the most important and often overlooked drivers of compliance and transparency reporting success: data quality.

The conversation examines where data quality issues originate, why transparency reporting cannot be owned by compliance alone and how organizations can strengthen governance, accountability and reporting accuracy.

Through practical examples, they discuss common challenges involving attendee data, vendor master records and manual entry, along with the processes and controls that help reduce reporting risk.

The panel also shares guidance for pre-commercial organizations building their compliance foundation and preparing for increasingly complex global reporting requirements.

Throughout the discussion, the panel outlines how strong reporting programs are built on better data capture, stronger processes and shared accountability across the organization.

Lisa Fontana and Christine Demetillo share how MedPro approached quality and ESG, from ISO and SOC 2 to CDP, EcoVadis and SBTi.

In Episode 3, Lisa Fontana and Christine Demetillo take listeners inside MedPro's quality and sustainability work. They share what it actually looked like to pursue four major frameworks at once (ISO 9001, ISO 27001, SOC 2 and the NIST Cybersecurity Framework) and why approaching them simultaneously was more efficient than tackling them one at a time.

The conversation then turns to ESG, where Christine breaks down the alphabet soup of acronyms (CDP, EcoVadis, SBTi and the EU CSRD) and explains how sustainability questions have moved from a passing trend to a permanent part of how companies evaluate their partners.

Along the way, Lisa and Christine explore the surprising overlap between quality and ESG, the real-world benefits they've seen since certifying in 2024 (faster customer audits, fewer questionnaire sections, stronger conversations with prospects) and a practical message for anyone feeling overwhelmed: most organizations are doing far more of the work than they realize.

Our Life Sciences experts unpack global transparency reporting, from Federal Open Payments misconceptions to GDPR impacts and a smarter country-by-country approach.

In Episode 2, our panel takes on one of the most complex compliance challenges facing Life Sciences: reporting transparency obligations across a global footprint. Scott McLean, Cristina List, Tenille Goodman and Jared Esposito unpack why U.S. Federal Open Payments (Sunshine Act) is often mistaken as the global standard and what companies actually face once they operate across multiple jurisdictions.

The conversation explores surprising nuances, from Oregon and Connecticut's zero-dollar interaction reporting to France's disclosure of agreements, Belgium's calendar-year lookback triggered by global commercial authorization and Italy's forthcoming date and place of birth requirement. The panel also examines why GDPR, consent, legitimate interest and the right to be forgotten have fundamentally reshaped how transparency data must be managed.

The panel closes with a practical view of why successful global programs are built intentionally and scaled thoughtfully, starting with a single country and expanding from there.

Our panel shares what they're hearing from the field, from the friction of consolidation to why AI is only as strong as the data behind it.

In Episode 1, our panel goes beyond the headlines to share what we're hearing directly from the field. Scott McLean, Bryan Andrews, Dan Loeffler and Christine Demetillo talk candidly about the realities customers are facing, from the friction of consolidation and the trade-offs of closed platforms to the pressure to make critical decisions with imperfect information. They share examples of how AI becomes powerful only when it is fueled by accurate, trusted data and why choosing the right platform early can give organizations a strategic advantage as they evaluate their CRM options.

Panel: Scott McLean, Executive Director of Sales; Bryan Andrews, Senior Director of Business Development and Partnerships; Dan Loeffler, Vice President of Customer Experience; Christine Demetillo, Product Specialist.